Early prediction of disability progression in multiple sclerosis (MS) remains challenging despite its critical importance for therapeutic decision-making. We present the first systematic evaluation of personalized federated learning (PFL) for 2-year MS disability progression…
Continue Reading
What You Should Know:
– Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced that its international oncology research network has tripled in size…
Continue Reading
The widespread adoption of real-world data has given rise to numerous healthcare-distributed research networks, but multi-site analyses still face administrative burdens and data privacy challenges. In response, we developed a Collaborative One-shot Lossless Algorithm…
Continue Reading
Real-world data (RWD) from electronic health records and digital health databases present unique opportunities to study causal effects in healthcare. While Difference-in-Differences (DiD) analysis is widely used for such analyses, it can be biased…
Continue Reading
In this interview, Julia Goebel, Chief Marketing Officer at Komodo Health, surveys the current state of health care data, the importance of high-quality data in the deployment of new technologies such as AI, and…
Continue Reading
Clinical insights from real-world data often require aggregating information from institutions to ensure sufficient sample sizes and generalizability. However, patient privacy concerns only limit the sharing of patient-level data, and traditional federated learning algorithms,…
Continue Reading
Subspecialty knowledge barriers have limited the adoption of large language models (LLMs) in oncology. We introduce Woollie, an open-source, oncology-specific LLM trained on real-world data from Memorial Sloan Kettering Cancer Center (MSK) across lung,…
Continue Reading
Dr. Heather Moss, Medical Advisor at Verana Health & Professor of Ophthalmology and of Neurology and Neurological Sciences at Stanford University
Parkinson’s Disease (PD) is considered one of the most complex and challenging neurodegenerative disorders…
Continue Reading
Natalie Schibell, VP of Market Strategy and Communications at Aetion,
Real-world evidence (RWE) has become central to evaluating therapies, medical products, and health interventions—providing insight into how they perform outside controlled clinical trials. As healthcare…
Continue Reading
Viraj Narayanan, CEO at Cornerstone AI
Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb
Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long…
Continue Reading
